Long-term safety and effectiveness of canakinumab in CAPS: results from the β-Confident Registry
Kuemmerle-Deschner JB, Ramos E, Engel K, et al.
RMD Open · 2021
Grade Bcohort
Key Findings
- ●Real-world registry
- ●6-year safety and effectiveness data
Referenced in (1 disease)
ID: pmid-34001647PMID: 34001647